Thus, we first analyzed CFTR and the thrombophilia genetic markers (F2, F5, MTHFR, FXIIA1, FXIIIB, SERPIN1, FGB, ITGB3, AGT, ACE, APOE) to verify the detected variants/sample. This evidence concerns the gene AGT and Rare hereditary thrombophilia.